Medicinal Products

Triumeq

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Triumeq
Active Substance dolutegravirnatrij, abakavirsulfat, lamivudin
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code J05AR13
Medicinal product marketed in the Croatia Da
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download
Educational materials
for healthcare professionals
Prezentacija za zdravstvene radnike, verzija 3

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o oštećenjima neuralne cijevi u novorođenčadi čije su majke bile izložene dolutegraviru u trenutku začeća 11.06.2018 ViiV Healthcare
Back